673 related articles for article (PubMed ID: 20639188)
1. Kynurenine and its metabolites in Alzheimer's disease patients.
Gulaj E; Pawlak K; Bien B; Pawlak D
Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
[TBL] [Abstract][Full Text] [Related]
2. Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.
Schwarz MJ; Guillemin GJ; Teipel SJ; Buerger K; Hampel H
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):345-52. PubMed ID: 23192697
[TBL] [Abstract][Full Text] [Related]
3. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
4. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
[TBL] [Abstract][Full Text] [Related]
5. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17():47. PubMed ID: 27130315
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine Pathway Metabolites in Alzheimer's Disease.
Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
[TBL] [Abstract][Full Text] [Related]
7. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
[TBL] [Abstract][Full Text] [Related]
9. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
[TBL] [Abstract][Full Text] [Related]
10. Low Serum Tryptophan Levels as an Indicator of Global Cognitive Performance in Nondemented Women over 50 Years of Age.
Ramos-Chávez LA; Roldán-Roldán G; García-Juárez B; González-Esquivel D; Pérez de la Cruz G; Pineda B; Ramírez-Ortega D; García Muñoz I; Jiménez Herrera B; Ríos C; Gómez-Manzo S; Marcial-Quino J; Sánchez Chapul L; Carrillo Mora P; Pérez de la Cruz V
Oxid Med Cell Longev; 2018; 2018():8604718. PubMed ID: 30584466
[TBL] [Abstract][Full Text] [Related]
11. A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.
Orsatti L; Speziale R; Orsale MV; Caretti F; Veneziano M; Zini M; Monteagudo E; Lyons K; Beconi M; Chan K; Herbst T; Toledo-Sherman L; Munoz-Sanjuan I; Bonelli F; Dominguez C
J Pharm Biomed Anal; 2015 Mar; 107():426-31. PubMed ID: 25668794
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Möller M; Du Preez JL; Harvey BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
[TBL] [Abstract][Full Text] [Related]
14. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
17. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
18. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
